MedPath

Goal Directed Fluid Therapy Guided Fluid Management in Pneumoresection

Not Applicable
Completed
Conditions
Goal-directed Fluid Therapy
Interventions
Device: Fluid therapy
Registration Number
NCT03237351
Lead Sponsor
ZhiHeng Liu
Brief Summary

Perioperative fluid management is a key component of anesthetic management during thoracic surgery. On one hand, fluid restriction could compromise perfusion of vital organs and surgical anastomosis. On the other hand, fluid overload could lead to cardiopulmonary complications, notably pulmonary edema, which carries a high mortality rate. Perioperative fluid management to avoid postpneumonectomy pulmonary edema has been previously reviewed. Therefore, to achieve the balance between preventing fluid overload and optimising organ perfusion, the practical index to guide fluid management, which can predict whether fluid loading will improve haemodynamic conditions in an individual patient, would be very valuable during lung surgery. Perioperative goal-directed fluid therapy (GDFT) is a cornerstone of tissue perfusion and oxygenation, and it can improve surgical outcomes. Respiratory variations of arterial pressure \[i.e. pulse pressure variation (PPV) and systolic pressure variation\] can predict fluid responsiveness in mechanically ventilated patients under various conditions. Therefore, pressure variations are increasingly being advocated for fluid management.This study will discuss the effects of pulse pressure variation(PPV) in different level during anesthesia on patients with oxygenation index and short-term prognosis undergoing video-assisted thoracoscopic surgery for pneumoresection.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
60
Inclusion Criteria
  • American Society of Anesthesiologists physical status I-III; aged 18-60 years old; BMI 18.5 ~ 28 kg/m2
Exclusion Criteria
  • Refused to participate in the experiment, hepatic/renal/cardiac dysfunction, severe valvular disease, frequent arrhythmia, moderate anemia and severe electrolyte disturbance before operation.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Conventional therapy groupFluid therapyPatients in Conventional therapy group were received fluid therapy: intraoperative transfusion volume=maintenance fluids+deficit replacement+restoration of losses and with heart rate, mean arterial pressure, urine measurement ect.
Low value of PPV groupFluid therapyPatients in low value of PPV group were received fluid therapy according to PPV (3% ≤PPV \< 5%) .
High value of PPV groupFluid therapyPatients in high value of PPV group were received fluid therapy according to PPV (5% ≤PPV \< 8%) .
Primary Outcome Measures
NameTimeMethod
Change from Baseline Oxygenation Index in 48 hoursBefore induction, 5 minutes before the end of one-lung ventilation, 48 hours after the operation
Secondary Outcome Measures
NameTimeMethod
The duration of surgeryDuring surgery period
The duration of mechanical ventilationDuring surgery period
Urine outputDuring surgery period
Blood pressureBefore the surgery and 48 hours after surgery
LeukocyteBefore the surgery and 48 hours after surgery
HematocritBefore the surgery and 48 hours after surgery
Hospital stay postoperatively1 month after surgery
Crystalloid administeredDuring surgery period
Complication until hospital discharge1 month after surgery
Colloid administeredDuring surgery period
Blood lossDuring surgery period
Number of patients received vasopressorDuring surgery period

Trial Locations

Locations (1)

Shenzhen Second People's Hospital

🇨🇳

Shenzhen, Guangdong, China

© Copyright 2025. All Rights Reserved by MedPath